Autologous stem cell therapy for peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials

Cell therapy for peripheral artery disease

(2018) Nikolaos G Frangogiannis   CURRENT OPINION IN PHARMACOLOGY

Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study

(2018) Xiaomei Zhang et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia

(2015) Jan Skóra et al.   Archives of Medical Science

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

(2015) M. Teraa et al.   CIRCULATION

Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial

(2014) Amish N. Raval et al.   CYTOTHERAPY

Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial

(2014) AW Bradbury et al.   HEALTH TECHNOLOGY ASSESSMENT

Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease—results of the short- and long-term follow-up

(2013) Gábor Viktor Szabó et al.   CYTOTHERAPY

Therapeutic Outcomes of Transplanting Autologous Granulocyte Colony-stimulating Factor-mobilised Peripheral Mononuclear Cells in Diabetic Patients with Critical Limb Ischaemia

(2013) L. Mohammadzadeh et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Autologous Bone Marrow Mononuclear Cells Transplant in Patients With Critical Leg Ischemia: Preliminary Clinical Results

(2013) Min Li et al.   Experimental and Clinical Transplantation

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

(2013) Pawan K Gupta et al.   Journal of Translational Medicine

A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia

(2012) Douglas W. Losordo et al.   Circulation-Cardiovascular Interventions

Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia

(2012) Ahmet Ozturk et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial

(2012) Richard J Powell et al.   MOLECULAR THERAPY

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

(2011) Dirk H. Walter et al.   Circulation-Cardiovascular Interventions

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

(2011) Debin Lu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

(2011) Eric Benoit et al.   Journal of Translational Medicine

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia

(2011) Richard J. Powell et al.   JOURNAL OF VASCULAR SURGERY

Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia

(2011) Mark D. Iafrati et al.   JOURNAL OF VASCULAR SURGERY

Cell Therapy, a New Standard in Management of Chronic Critical Limb Ischemia and Foot Ulcer

(2010) V. Procházka et al.   CELL TRANSPLANTATION

Stem Cell Therapy in PAD

(2010) R.W. Sprengers et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells

(2009) Takashi Horie et al.   ATHEROSCLEROSIS

Stem cell therapy for critical limb ischaemia — a review

(2009) Anjan Kumar Das   Indian Journal of Surgery

Targeting Nonhealing Ulcers of Lower Extremity in Human Through Autologous Bone Marrow-Derived Mesenchymal Stem Cells

(2009) Nihar Ranjan Dash et al.   REJUVENATION RESEARCH

Antithrombotic Therapy for Peripheral Artery Occlusive Disease

(2008) Michael Sobel et al.   CHEST

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal